N@N

RPT, OMG, MDCA, REGN, CALP, MDF Expected To Be Up Before Next Earnings Releases

^{Published on 2011-07-19 06:41:19 - WOPRAI}
 

July 19, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. RAMCO-GERSHENSON PROPERTIES (NYSE:RPT), OM GROUP INC (NYSE:OMG), MDC PARTNERS INCORPORATED (NASDAQ:MDCA), REGENERON PHARMACEUTICALS (NASDAQ:REGN), CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP), METRO HEALTH NETWORKS INC (AMEX:MDF) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Tuesday:

     Symbol     Company                             # of Reports            Quarter     Release Date
     RPT        RAMCO-GERSHENSON PROPERTIES         6 Quarter               Q2          07/26/2011
     OMG        OM GROUP INC                        6 Quarter               Q2          08/04/2011
     MDCA       MDC PARTNERS INCORPORATED           12 Quarter              Q2          07/28/2011
     REGN       REGENERON PHARMACEUTICALS           12 Quarter              Q2          07/28/2011
     CALP       CALIPER LIFE SCIENCES, INC.         6 Quarter               Q2          08/03/2011
     MDF        METRO HEALTH NETWORKS INC           12 Quarter              Q2          08/03/2011

RAMCO-GERSHENSON PROPERTIES (NYSE:RPT) - Ramco-Gershenson Properties Trust, a real estate investment trust (REIT), engages in the ownership, development, acquisition, management, and leasing of community shopping centers, single tenant retail properties, and one regional mall in the Midwestern, Southeastern, and Mid-Atlantic regions of the United States. As of December 31, 2007, the company owned interests in 89 shopping centers, which included 65 community centers, 21 power centers, 2 single tenant retail properties, and 1 enclosed regional mall. Ramco-Gershenson Properties has elected to be a taxable REIT for federal income tax purposes. As a REIT, it would not be subject to federal income taxes, if it distributes approximately 90% of its taxable income to its shareholders. The company was founded in 1988 and is based in Farmington Hills, Michigan with additional office in Boca Raton, Florida.

OM GROUP INC (NYSE:OMG) - OM Group, Inc. engages in the development, production, and marketing of specialty chemicals and advanced materials to complex chemical and industrial processes worldwide. The company operates in two segments: Advanced Materials and Specialty Chemicals. The Advanced Materials segment manufactures inorganic products using unrefined cobalt and other metals and serves the battery materials, powder metallurgy, and ceramic and chemical end markets. It offers chemicals, pigments and ceramics, battery materials, and various raw materials. These products improve the electrical conduction of rechargeable batteries used in cellular phones, video cameras, portable computers, power tools, and hybrid electrical vehicles, as well as strengthen and add durability to diamond and machine cutting tools and drilling equipment used in construction, oil and gas drilling, and quarrying. The Specialty Chemicals segment offers electronic chemicals for the printed circuit boards, memory disks, general metal finishing, and electronic packaging and finishing markets. This segment also provides advanced organics comprising additives and driers for paints, and printing inks; rubber adhesion promoters; composite and other catalysts; and fuel oil additives, lubricants, and grease additives. In addition, it offers ultra pure chemicals used in the manufacture of electronic and computer components, such as semiconductors, silicon chips, wafers, and liquid crystal displays; and photo-imaging masks, including high-purity quartz or glass plates containing precision, microscopic images of integrated circuits; and reticles for the semiconductor, optoelectronics, and microelectronics industries under the Compugraphics brand name. The company was founded in 1991 and is headquartered in Cleveland, Ohio.

MDC PARTNERS INCORPORATED (NASDAQ:MDCA) - MDC Partners, Inc., through its subsidiaries, provides marketing communications and consulting services primarily in the United States, Canada, Europe, and Jamaica. The companys Strategic Marketing Services segment provides a suite of integrated marketing communication and consulting services, including advertising and media, interactive and direct marketing, public relations, corporate communications, market research, corporate identity and branding, and sales promotion services. Its Performance Marketing Services segment provides services, including the design, development, and implementation of customer service and direct marketing initiative. MDC Partners also provides retail and event marketing, consumer promotions, database and customer relationship management, design and branding, and related services. The company was formerly known as MDC Corporation Inc. and changed its name to MDC Partners, Inc. in January 2004. MDC Partners was founded in 1980 and is headquartered in Toronto, Canada.

REGENERON PHARMACEUTICALS (NASDAQ:REGN) - Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The companys commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical trials include Rilonacept for the prevention and treatment of gout-related flares; VEGF Trap-Eye for eye diseases using intraocular delivery; and Aflibercept for the treatment of oncology. The companys earlier stage clinical programs REGN475, an antibody to nerve growth factor, which is being developed for the treatment of pain; REGN88, an antibody to the interleukin-6 receptor, which is developed in rheumatoid arthritis; REGN421, an antibody to delta-like ligand-4, for the treatment of oncology; REGN727, an antibody to proprotein convertase substilisin/kexin type 9, which is developed for low density lipoprotein cholesterol reduction; and REGN668, an antibody to the interleukin-4 receptor for certain allergic and immune conditions. Regeneron Pharmaceuticals also conducts other preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize fully human monoclonal antibodies; and Bayer HealthCare LLC for the development of the VEGF-Trap-Eye. Regeneron Pharmaceuticals was founded in 1988 and is based in Tarrytown, New York.

CALIPER LIFE SCIENCES, INC. (NASDAQ:CALP) - Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The companys products also comprise LabChip GX series of instruments targeted at genomics applications; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; TurboVap family of evaporators; and RapidTrace solid phase extraction workstation. In addition, it offers contract research services, drug discovery and development services, alliances and integrated research programs, environmental testing, and product support services. Caliper Life Sciences sells its products through direct sales force, a network of distributors, partnership channels, and joint marketing agreements. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

METRO HEALTH NETWORKS INC (AMEX:MDF) - Metropolitan Health Networks, Inc., through its subsidiaries, operates provider service networks (PSN) in the United States. Its PSN provides and arranges healthcare services to Medicare Advantage beneficiaries who participate in a Medicare Advantage plan. The company offers Medicare, a national health insurance program that covers the cost of hospitalization, medical care, and related health services for the U.S. citizens aged 65 and older, qualifying disabled persons, and persons suffering from end-staged renal disease. As of December 31, 2009, the PSN provided healthcare benefits to approximately 35,500 medicare advantage beneficiaries. The company was founded in 1996 and is headquartered in West Palm Beach, Florida.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641